Ecologic Barrier
Commercial- Indications
- Brain health, Mood disorders
Company intelligence / Profile preview
Winclove Probiotics
Amsterdam, North Holland, Netherlandswincloveprobiotics.com ↗
- Ownership
- Private
- Employees
- ~96
- Development stage
- Commercial
01
Overview
Winclove produces premium, evidence-based probiotic formulations for various health indications, with their first probiotic containing vitamin B12 receiving a European health claim in 2017.
- Therapeutic areas
- GastroenterologyDermatologyImmunologyInfectious Diseases
- Modalities
- Probiotic formulations
- Industry
- Food & Nutrition
02
Drug pipeline
1 asset03
Partnerships
Research institutesuniversity hospitalsbusiness partners worldwide
Beyond the preview
Go deeper on Winclove Probiotics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Winclove Probiotics.